These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 1851034

  • 1. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
    Faint RW, Mackie IJ, Machin SJ.
    Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
    [Abstract] [Full Text] [Related]

  • 2. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.
    Salvemini D, de Nucci G, Gryglewski RJ, Vane JR.
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6328-32. PubMed ID: 2548208
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative platelet inhibitory effects of human neutrophils and lymphocytes.
    Nicolini FA, Wilson AC, Mehta P, Mehta JL.
    J Lab Clin Med; 1990 Aug; 116(2):147-52. PubMed ID: 2168463
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: comparison with ATP, adenosine and guanosine.
    Vuorinen P, Laustiola KE.
    Pharmacol Toxicol; 1992 Oct; 71(4):289-93. PubMed ID: 1333596
    [Abstract] [Full Text] [Related]

  • 8. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.
    De La Cruz JP, Páez MV, Carmona JA, De La Cuesta FS.
    Br J Pharmacol; 1999 Dec; 128(7):1538-44. PubMed ID: 10602334
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW, Palmer RM, Moncada S.
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.
    Boulanger C, Schini VB, Moncada S, Vanhoutte PM.
    Br J Pharmacol; 1990 Sep; 101(1):152-6. PubMed ID: 2178013
    [Abstract] [Full Text] [Related]

  • 11. [The effect of triflusal on human platelet aggregation and secretion: the role of nitric oxide].
    Sánchez de Miguel L, Montón M, Mar Arriero M, Guerra JI, Jiménez A, González-Fernández F, García-Durán M, Bellver T, Rico L, Romero J, Gómez J, Núñez A, Marcos P, Ayala R, Farré J, Casado S, López-Farré A.
    Rev Esp Cardiol; 2000 Feb; 53(2):205-11. PubMed ID: 10734753
    [Abstract] [Full Text] [Related]

  • 12. Nitrovasodilators and cGMP inhibit human platelet activation.
    Doni MG, Alexandre A, Padoin E, Bertoncello S, Deana R.
    Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321
    [Abstract] [Full Text] [Related]

  • 13. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells.
    Durante W, Schini VB, Scott-Burden T, Junquero DC, Kroll MH, Vanhoutte PM, Schafer AI.
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H2024-30. PubMed ID: 1661096
    [Abstract] [Full Text] [Related]

  • 14. L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent.
    Anfossi G, Russo I, Massucco P, Mattiello L, Perna P, Tassone F, Trovati M.
    Thromb Res; 1999 Jun 01; 94(5):307-16. PubMed ID: 10379819
    [Abstract] [Full Text] [Related]

  • 15. Effect of trilinolein on cyclic nucleotide formation in human platelets: relationship with its antiplatelet effect and nitric oxide synthesis.
    Shen YC, Hong CY.
    Br J Pharmacol; 1995 Sep 01; 116(1):1644-8. PubMed ID: 8564231
    [Abstract] [Full Text] [Related]

  • 16. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process.
    Chou TC, Li CY, Yen MH, Ding YA.
    Biochem Pharmacol; 1999 Nov 15; 58(10):1657-63. PubMed ID: 10535758
    [Abstract] [Full Text] [Related]

  • 17. N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets.
    Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Trovati M.
    Eur J Clin Invest; 2001 May 15; 31(5):452-61. PubMed ID: 11380598
    [Abstract] [Full Text] [Related]

  • 18. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM, Böger RH, Galland A, Frölich JC.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb 15; 357(2):143-50. PubMed ID: 9521487
    [Abstract] [Full Text] [Related]

  • 19. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.
    de la Cruz JP, Guerrero A, González-Correa JA, Márquez E, Nacle I, Sánchez de la Cuesta F.
    Eur J Clin Pharmacol; 2002 Jan 15; 57(11):775-80. PubMed ID: 11871383
    [Abstract] [Full Text] [Related]

  • 20. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH, Cheng JT, Teng CM.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):158-67. PubMed ID: 16112105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.